Synthesis of Aβ(1-42) and its derivatives with improved efficiency

Márta Zarándi, K. Soós, L. Fülöp, Z. Bozsó, Zsolt Datki, G. Tóth, B. Penke

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

It has been proved that the principal component of senile plaques is aggregates of β-amyloid peptide (Aβ) in cases of one of the most common forms of age-related neurodegenerative disorders, Alzheimer's disease (AD). Although the synthetic methods for the synthesis of Aβ peptides have been developed since their first syntheses, Aβ[1-42] is still problematic to prepare. The highly hydrophobic composition of Aβ[1-42] results in aggregation between resin-bound peptide chains or intrachain aggregation which leads to a decrease in the rates of deprotection and repetitive incomplete coupling reactions during 9-flurenylmethoxycarbonyl (Fmoc) synthesis. In order to avoid aggregation and/or disrupt internal aggregation during stepwise Fmoc solid phase synthesis and to improve the quality of crude products, several attempts have been made. Since highly pure Aβ peptides in large quantities are used in biological experiments, we wanted to develop a method for a rational synthesis of human Aβ[1-42] with high purity and adequate yield. This paper reports a convenient methodology with a novel solvent system for the synthesis of Aβ[1-42], its N-terminally truncated derivatives Aβ[4-42] and Aβ[5-42], and Aβ[1-421 labeled with 7-amino-4-methyl-3-coumarinylacetic acid (AMCA) at the N-terminus using Fmoc strategy. The use of 10% anisole in Dimethylformamide/ Dichloromethane (DMF/DCM) can substantially improve the purity and yield of crude Aβ[1-42] and has been shown to be an optimal coupling condition for the synthesis of Aβ[1-42]. Anisole is a cheap and simple aid in the synthesis of 'difficult sequences' where other solvents are less successful in the prevention of aggregation during the synthesis.

Original languageEnglish
Pages (from-to)94-99
Number of pages6
JournalJournal of Peptide Science
Volume13
Issue number2
DOIs
Publication statusPublished - Feb 2007

Fingerprint

Derivatives
Synthetic Chemistry Techniques
Dimethylformamide
Peptides
Solid-Phase Synthesis Techniques
Methylene Chloride
Amyloid Plaques
Amyloid
Neurodegenerative Diseases
Agglomeration
Alzheimer Disease
anisole
Resins
7-amino-4-methyl-3-coumarinylacetic acid
peptide A
Acids
Chemical analysis
Experiments

Keywords

  • Alzheimer's disease
  • Beta-amyloid
  • Difficult sequences
  • Labeling of beta-amyloid
  • Neurodegeneration
  • Synthesis

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry

Cite this

Synthesis of Aβ(1-42) and its derivatives with improved efficiency. / Zarándi, Márta; Soós, K.; Fülöp, L.; Bozsó, Z.; Datki, Zsolt; Tóth, G.; Penke, B.

In: Journal of Peptide Science, Vol. 13, No. 2, 02.2007, p. 94-99.

Research output: Contribution to journalArticle

@article{0cc783d472c04bd5b3f0d7767cc318c6,
title = "Synthesis of Aβ(1-42) and its derivatives with improved efficiency",
abstract = "It has been proved that the principal component of senile plaques is aggregates of β-amyloid peptide (Aβ) in cases of one of the most common forms of age-related neurodegenerative disorders, Alzheimer's disease (AD). Although the synthetic methods for the synthesis of Aβ peptides have been developed since their first syntheses, Aβ[1-42] is still problematic to prepare. The highly hydrophobic composition of Aβ[1-42] results in aggregation between resin-bound peptide chains or intrachain aggregation which leads to a decrease in the rates of deprotection and repetitive incomplete coupling reactions during 9-flurenylmethoxycarbonyl (Fmoc) synthesis. In order to avoid aggregation and/or disrupt internal aggregation during stepwise Fmoc solid phase synthesis and to improve the quality of crude products, several attempts have been made. Since highly pure Aβ peptides in large quantities are used in biological experiments, we wanted to develop a method for a rational synthesis of human Aβ[1-42] with high purity and adequate yield. This paper reports a convenient methodology with a novel solvent system for the synthesis of Aβ[1-42], its N-terminally truncated derivatives Aβ[4-42] and Aβ[5-42], and Aβ[1-421 labeled with 7-amino-4-methyl-3-coumarinylacetic acid (AMCA) at the N-terminus using Fmoc strategy. The use of 10{\%} anisole in Dimethylformamide/ Dichloromethane (DMF/DCM) can substantially improve the purity and yield of crude Aβ[1-42] and has been shown to be an optimal coupling condition for the synthesis of Aβ[1-42]. Anisole is a cheap and simple aid in the synthesis of 'difficult sequences' where other solvents are less successful in the prevention of aggregation during the synthesis.",
keywords = "Alzheimer's disease, Beta-amyloid, Difficult sequences, Labeling of beta-amyloid, Neurodegeneration, Synthesis",
author = "M{\'a}rta Zar{\'a}ndi and K. So{\'o}s and L. F{\"u}l{\"o}p and Z. Bozs{\'o} and Zsolt Datki and G. T{\'o}th and B. Penke",
year = "2007",
month = "2",
doi = "10.1002/psc.801",
language = "English",
volume = "13",
pages = "94--99",
journal = "Journal of Peptide Science",
issn = "1075-2617",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Synthesis of Aβ(1-42) and its derivatives with improved efficiency

AU - Zarándi, Márta

AU - Soós, K.

AU - Fülöp, L.

AU - Bozsó, Z.

AU - Datki, Zsolt

AU - Tóth, G.

AU - Penke, B.

PY - 2007/2

Y1 - 2007/2

N2 - It has been proved that the principal component of senile plaques is aggregates of β-amyloid peptide (Aβ) in cases of one of the most common forms of age-related neurodegenerative disorders, Alzheimer's disease (AD). Although the synthetic methods for the synthesis of Aβ peptides have been developed since their first syntheses, Aβ[1-42] is still problematic to prepare. The highly hydrophobic composition of Aβ[1-42] results in aggregation between resin-bound peptide chains or intrachain aggregation which leads to a decrease in the rates of deprotection and repetitive incomplete coupling reactions during 9-flurenylmethoxycarbonyl (Fmoc) synthesis. In order to avoid aggregation and/or disrupt internal aggregation during stepwise Fmoc solid phase synthesis and to improve the quality of crude products, several attempts have been made. Since highly pure Aβ peptides in large quantities are used in biological experiments, we wanted to develop a method for a rational synthesis of human Aβ[1-42] with high purity and adequate yield. This paper reports a convenient methodology with a novel solvent system for the synthesis of Aβ[1-42], its N-terminally truncated derivatives Aβ[4-42] and Aβ[5-42], and Aβ[1-421 labeled with 7-amino-4-methyl-3-coumarinylacetic acid (AMCA) at the N-terminus using Fmoc strategy. The use of 10% anisole in Dimethylformamide/ Dichloromethane (DMF/DCM) can substantially improve the purity and yield of crude Aβ[1-42] and has been shown to be an optimal coupling condition for the synthesis of Aβ[1-42]. Anisole is a cheap and simple aid in the synthesis of 'difficult sequences' where other solvents are less successful in the prevention of aggregation during the synthesis.

AB - It has been proved that the principal component of senile plaques is aggregates of β-amyloid peptide (Aβ) in cases of one of the most common forms of age-related neurodegenerative disorders, Alzheimer's disease (AD). Although the synthetic methods for the synthesis of Aβ peptides have been developed since their first syntheses, Aβ[1-42] is still problematic to prepare. The highly hydrophobic composition of Aβ[1-42] results in aggregation between resin-bound peptide chains or intrachain aggregation which leads to a decrease in the rates of deprotection and repetitive incomplete coupling reactions during 9-flurenylmethoxycarbonyl (Fmoc) synthesis. In order to avoid aggregation and/or disrupt internal aggregation during stepwise Fmoc solid phase synthesis and to improve the quality of crude products, several attempts have been made. Since highly pure Aβ peptides in large quantities are used in biological experiments, we wanted to develop a method for a rational synthesis of human Aβ[1-42] with high purity and adequate yield. This paper reports a convenient methodology with a novel solvent system for the synthesis of Aβ[1-42], its N-terminally truncated derivatives Aβ[4-42] and Aβ[5-42], and Aβ[1-421 labeled with 7-amino-4-methyl-3-coumarinylacetic acid (AMCA) at the N-terminus using Fmoc strategy. The use of 10% anisole in Dimethylformamide/ Dichloromethane (DMF/DCM) can substantially improve the purity and yield of crude Aβ[1-42] and has been shown to be an optimal coupling condition for the synthesis of Aβ[1-42]. Anisole is a cheap and simple aid in the synthesis of 'difficult sequences' where other solvents are less successful in the prevention of aggregation during the synthesis.

KW - Alzheimer's disease

KW - Beta-amyloid

KW - Difficult sequences

KW - Labeling of beta-amyloid

KW - Neurodegeneration

KW - Synthesis

UR - http://www.scopus.com/inward/record.url?scp=33847103583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847103583&partnerID=8YFLogxK

U2 - 10.1002/psc.801

DO - 10.1002/psc.801

M3 - Article

C2 - 17103463

AN - SCOPUS:33847103583

VL - 13

SP - 94

EP - 99

JO - Journal of Peptide Science

JF - Journal of Peptide Science

SN - 1075-2617

IS - 2

ER -